Reducing smoking by half in COPD patients: Does it reduce FEV1 decline?

被引：4
|
作者：
Peiffer, G. [1 ]
Perriot, J. [2 ,3 ]
Underner, M. [4 ,5 ]
机构：
[1] Hop Metz, CHR Metz Thionville, Serv Pneumol, Ctr Tabacol, F-57038 Metz 3, France
[2] Ctr Tabacol, Dispensaire Emile Roux, F-63100 Clermont Ferrand, France
[3] Ctr Lutte AntiTB CLAT 63, F-63100 Clermont Ferrand, France
[4] CHU Poitiers, Serv Pneumol, Unite Tabacol, F-86000 Poitiers, France
[5] CHU Poitiers, Ctr Lutte AntiTB CLAT 63, F-86000 Poitiers, France
来源：
REVUE DES MALADIES RESPIRATOIRES | 2017年 / 34卷 / 03期
关键词：
NICOTINE REPLACEMENT THERAPY; LUNG HEALTH; CESSATION; DISEASE; SMOKERS; SAFETY; RISK;
D O I：
10.1016/j.rmr.2016.10.872
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：177 / 179
页数：3
相关论文
共 50 条
  • [21] A pooled analysis of FEV1, decline in COPD patients randomized to inhaled corticosteroids or placebo
    Soriano, Joan B.
    Sin, Don D.
    Zhang, Xuekui
    Camp, Pat G.
    Anderson, Julie A.
    Anthonisen, Nick R.
    Buist, A. Sonia
    Burge, P. Sherwood
    Calverley, Peter M.
    Connett, John E.
    Petersson, Stefan
    Postma, Dirkje S.
    Szafranski, Wojciech
    Vestbo, Jorgen
    CHEST, 2007, 131 (03) : 682 - 689
  • [22] The Fev1/FVC Or Fev1/vc Ratio: Which Is A Better Predictor Of Fev1 Decline?
    Hyatt, R. E.
    Schroeder, D. R.
    Parker, K. O.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [23] Association of Dysanapsis with FEV1 Decline in Early COPD: The BEACON Cohort
    Ritchie, Andrew
    Donaldson, Gavin
    Hoffman, Eric
    Allinson, James
    Bloom, Chloe
    Smith, Benjamin
    Bolton, Charlotte
    Choudhury, Gourab
    Gerard, Sarah
    Guo, Junfeng
    Alves-Moreira, Luana
    Mcgarvey, Lorcan
    Sapey, Elizabeth
    Stockley, Robert
    Yip, Kp
    Singh, Dave
    Wilkinson, Tom
    Mullerova, Hana
    Ostridge, Kristoffer
    Joens, Olaf
    Bucchioni, Enrica
    Compton, Chris
    Jones, Paul
    Mezzi, Karen
    Vestbo, Jorgen
    Calverley, Peter
    Wedzicha, Jadwiga
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [24] FEV1/FEV6 May Misdiagnose Patients With COPD
    Ruppel, Gregg L.
    Haynes, Jeffrey M.
    Kaminsky, David A.
    RESPIRATORY CARE, 2016, 61 (07) : 999 - 1001
  • [25] Predictors of accelerated FEV1 decline in patients with rhinitis
    Omarjee, B.
    Budhan, S.
    Vellin, J. F.
    ALLERGY, 2020, 75 : 377 - 377
  • [26] Decline of FEV1 by age and smoking status: facts, figures, and fallacies
    Kerstjens, HAM
    Rijcken, B
    Schouten, JP
    Postma, DS
    THORAX, 1997, 52 (09) : 820 - 827
  • [27] Dyspnoea perception and FEV1 decline during Sputum Induction in Healthy Controls and COPD patients
    Rodrigues, Pedro
    Ostridge, Kristoffer
    Staples, Karl
    Gove, Kerry
    Bawden, Sarah
    Wilkinson, Tom
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [28] So inhaled steroids slow the rate of decline of FEV1 in patients with COPD after all?
    Burge, PS
    Lewis, SA
    THORAX, 2003, 58 (11) : 911 - 913
  • [29] INHALED STEROIDS REDUCE THE DECLINE IN FEV1 OVER 5 YEARS IN BOTH STEROID RESPONSIVE AND NONRESPONSIVE COPD
    SPENCE, DPS
    RIMINGTON, LD
    NISAR, M
    EARIS, JE
    CALVERLEY, PMA
    PEARSON, MG
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A315 - A315
  • [30] FEV1 for identification of low BMD in patients with COPD
    Brask-Rasmussen, D.
    Cadarette, S. M.
    Johnsen, C. R.
    Eskildsen, P. C.
    Abrahamsen, B.
    BONE, 2009, 44 (02) : S373 - S374
12345